LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification.